Drug intelligence / Profile preview

silver sulfadiazine + chlorhexidine gluconate

Development stage
Unknown
Lead developer
Bharat Biotech
Modality
Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
Administration
Topical
01

Overview

Silver sulfadiazine + chlorhexidine gluconate is a topical combination drug used primarily for the prevention and treatment of infections in burn wounds and other skin injuries. Silver sulfadiazine is a sulfonamide antibiotic that releases silver ions, which disrupt bacterial cell walls and inhibit folic acid synthesis required for bacterial growth. Chlorhexidine gluconate is an antiseptic that disrupts microbial cell membranes, providing broad-spectrum antimicrobial activity. Together, they offer synergistic action against a wide range of gram-positive and gram-negative bacteria—including resistant strains—making this combination especially effective in reducing wound sepsis risk in burn patients. The product is typically formulated as a cream or ointment for external use only[1][2][5][7].

Brand names
Silvazine
Other names
silver sulfadiazine and chlorhexidine gluconate creamSSD + CHGsilver sulphadiazine + chlorhexidine digluconate
02

Targets

PGN (Peptidoglycan)DHPS (Dihydropteroate synthase)

Beyond the preview

Go deeper on silver sulfadiazine + chlorhexidine gluconate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on silver sulfadiazine + chlorhexidine gluconate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call